- Report
- December 2024
- 201 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- December 2024
- 172 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- December 2024
- 201 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- November 2024
- 192 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- November 2024
- 200 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- November 2024
- 168 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- November 2024
- 151 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- November 2024
- 158 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- November 2024
- 157 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- August 2024
- 143 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- August 2024
- 163 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- August 2024
- 173 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- August 2024
- 166 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- August 2024
- 139 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- August 2024
- 145 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- August 2024
- 167 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- August 2024
- 170 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- July 2024
- 141 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- July 2024
- 160 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- July 2024
- 161 Pages
Global
From €2215EUR$2,500USD£1,901GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more